People in the News: Kirk Malloy, Marc Unger, and Ulrich Krauss | GenomeWeb

Kirk Malloy

NanoString Technologies has appointed Kirk Malloy to its Board of Directors. Malloy brings 20 years of experience in the life science tools, applied markets, and molecular diagnostics markets. He is the founder of consulting firm BioAdvisors, and was previously senior VP and general manager of life sciences and applied markets at Illumina. Prior to that, Malloy worked at Biosite and Qiagen. He also sits on the boards of publicly traded Organovo Holdings and the privately-held firms Edico Genome, iGenomx, and Agilome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.